in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—29 January
9:27 AM MST | January 29, 2013 | Deepti Ramesh
Lonza reports rises in profits and sales Lonza recorded an 18.2% rise in net profits for 2012 compared with 2011, to 182 million Swiss francs ($196 million). Sales for 2012 increased 45.8%, to SF3.92 billion. Lonza says it achieved solid sales growth in 2012 with stable market demand, and following the Arch acquisition, revenues increased by 45.8%. Lonza’s technology toolbox attracted new customers in all areas and led to satisfactory capacity utilization at all sites. The volatile macroeconomic situation was challenging, but Lonza managed to balance most...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee